APPLICATION OF PLATELET-RICH PLASMA IN REDUCTION OF GREATER TROCHANTERIC PAIN SYNDROME

• Main Authors: A. S. Bashkina, L. Y. Shirokova, T. S. Knyazeva, O. M. Parulya, E. B. Abrosimova, S. M. Noskov
• Format: Article
• Language: Russian
• Published: Vreden Russian Research Institute of Traumatology and Orthopedics 2011-06-01
• Series: Travmatologiâ i Ortopediâ Rossii
• Subjects: greater trochanteric pain syndrome; platelet-rich plasma; glucocorticosteroids; local therapy
• Online Access: https://journal.rniito.org/jour/article/view/423
• ISSN: 2311-2905; 2542-0933

The results of a comparative study of platelet-rich plasma (PRP) and glucocorticosteroids (GCS) for local treatment of greater trochanteric pain syndrome (GTPS) are presented. 40 patients with GTPS were randomized into groups of 20 persons. The condition of patients was analyzed on a scale of pain during the day (VAS) and index WOMAC. 40 women with GTPS at six months of observation show that the local injections of PRP is superior to therapy with corticosteroids. The data of the study allow to expand the scope of the PRP and the first to recommend this therapy for GTPS. Local PRP therapy is distinguished by the absence of undesirable reactions, and high efficiency in GTPS exceeding the glucocorticosteroids.